Adenocarcinoma
|
0.020 |
Biomarker
|
group |
BEFREE |
CD95L expression was characterized in immortalized squamous esophagus (HET-1A) and Barrett esophagus (BAR-T) cells; adenocarcinoma cell lines FLO-1, SEG-1, and BIC-1, and MDA468 (- control); and KFL cells (+ control).
|
21390183 |
2011 |
Adenocarcinoma
|
0.020 |
Biomarker
|
group |
BEFREE |
Human esophageal squamous epithelial (HET-1A) and adenocarcinoma (OE33) cells were subjected to acid treatment and used in transfection experiments.
|
20138038 |
2010 |
Adult Glioblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
SLC22A18, solute carrier family 22, member 18, has been proposed to function as a tumor suppressor based on its chromosomal location at 11p15.5, mutations and aberrant splicing in several types of cancer and down-regulation in glioblastoma.
|
26196590 |
2015 |
Adult Glioblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Predictive value of the SLC22A18 protein expression in glioblastoma patients receiving temozolomide therapy.
|
23514245 |
2013 |
Adult Glioblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Silencing SATB1 overcomes temozolomide resistance by downregulating MGMT expression and upregulating SLC22A18 expression in human glioblastoma cells.
|
30140041 |
2018 |
Adult Rhabdomyosarcoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Because this region frequently is altered in neoplasms and in the genetic disease Beckwith-Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith-Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T.
|
9520460 |
1998 |
Agnosia for Pain
|
0.010 |
Biomarker
|
disease |
BEFREE |
Eighty patients were randomized to receive either intrathecal morphine (Group ITM) or local infiltration analgesia (Group LIA) for pain management in a double-blind study.
|
28856511 |
2017 |
Alcoholic Intoxication, Chronic
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Combining evidence from the case-control study, the follow-up in families, and gene expression provided strongest support for the association of a cluster of genes on chromosome 11 (SLC22A18, PHLDA2, NAP1L4, SNORA54, CARS, and OSBPL5) with alcohol dependence.
|
20201924 |
2010 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Atherosclerosis was diagnosed by (carotid and femoral) ITM measurement and ABPI.
|
28146208 |
2017 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Atherosclerosis was diagnosed by (carotid and femoral) ITM measurement and ABPI.
|
28146208 |
2017 |
Autoimmune Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Polymorphisms of the NACHT [neuronal apoptosis inhibitory protein (NAIP), CIITA, HET-E, TP1] and leucine-rich repeat protein 1 (NLRP1) gene are reported to be associated with susceptibility to vitiligo and several autoimmune diseases.
|
21331694 |
2011 |
Barrett Esophagus
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Normal esophageal epithelium and HET-1A cells (derived from normal squamous epithelium) show high levels of Beclin-1, but lower levels of Beclin-1 were found in BE and EAC cell lines (CP-A, CP-C, and OE33).
|
22301112 |
2012 |
Barrett Esophagus
|
0.050 |
Biomarker
|
disease |
BEFREE |
One such gene, tribbles-homology-3 (TRB3) was induced specifically in HET-1A cells, absent in SKGT4 cells and decreased in BO samples in silico and in vivo.
|
20139130 |
2010 |
Barrett Esophagus
|
0.050 |
Biomarker
|
disease |
BEFREE |
The proliferative effect of miRNA-145 precursor transfection in the SQ (HET-1A) and BE cell line (BAR-T) was measured.
|
22504665 |
2013 |
Barrett Esophagus
|
0.050 |
Biomarker
|
disease |
BEFREE |
Cell line models of squamous epithelium (HET-1A) and BO (QH) were used to examine the effects of bile acids on cell adhesion to extracellular matrix proteins (Collagen, laminin, vitronectin, fibronectin) and expression of integrin ligands (α<sub>3</sub> , α<sub>4,</sub> α<sub>5</sub> , α<sub>6</sub> and α<sub>ν</sub> ).
|
28941013 |
2017 |
Barrett Esophagus
|
0.050 |
Biomarker
|
disease |
BEFREE |
CD95L expression was characterized in immortalized squamous esophagus (HET-1A) and Barrett esophagus (BAR-T) cells; adenocarcinoma cell lines FLO-1, SEG-1, and BIC-1, and MDA468 (- control); and KFL cells (+ control).
|
21390183 |
2011 |
Barrett's Adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hsp27 protein was inducible by heat shock in Barrett's adenocarcinoma cell lines and an immortalized oesophageal epithelial cell line (HET-1A), but not by oestradiol.
|
10027336 |
1999 |
Beckwith-Wiedemann Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Because this region frequently is altered in neoplasms and in the genetic disease Beckwith-Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith-Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T.
|
9520460 |
1998 |
Bilirubin level result
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
Bilirubin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
Bilirubin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases.
|
29403010 |
2018 |
Bilirubin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association meta-analysis for total serum bilirubin levels.
|
19414484 |
2009 |
Breast Cancer, Familial
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Breast Carcinoma
|
0.460 |
AlteredExpression
|
disease |
BEFREE |
The results of Kaplan-Meier analysis indicated that SLC22A18 expression was associated with relapse-free survival (RFS) of breast cancer.
|
21144813 |
2011 |
Breast Carcinoma
|
0.460 |
Biomarker
|
disease |
CTD_human |
|
|
|